Armistice Capital’s SkinHealth Systems SKIN Stock Holding History

Armistice Capital’s Portfolio SKIN Stock Details SKIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-200,000	Closed	-$1.67M	–	279
2023 Q2	$1.67M	Buy	+200,000	New	+$2.08M	0.02%	155

Other funds holding SKIN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

LCG

Luxor Capital Group New York $2.52B AUM 29.31% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Armistice Capital's SKIN Position: Q3 2023 in Review

Armistice Capital sold out of SkinHealth Systems (SKIN) in Q3 2023, closing a stake of 200,000 shares — an estimated $1.67M sold.

Armistice Capital first reported a position in SKIN in Q2 2023 and held it in 1 quarter. The position peaked at $1.67M in Q2 2023. 135 funds tracked by Wall St. Rank hold SKIN as of Q3 2023.

Armistice Capital reported no remaining SkinHealth Systems position as of Q3 2023 after selling out during the quarter.
Armistice Capital sold 200,000 SkinHealth Systems shares in Q3 2023, an estimated $1.67M.
Armistice Capital first reported a position in SkinHealth Systems in Q2 2023 and held it in 1 quarter.
Armistice Capital's SkinHealth Systems position peaked at $1.67M in Q2 2023.
135 funds tracked by Wall St. Rank held SkinHealth Systems as of Q3 2023.

Based on Armistice Capital's 13F filing for Q3 2023, filed 14 Nov 2023.